Free Trial

Grove Bank & Trust Cuts Position in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Grove Bank & Trust reduced its stake in UnitedHealth Group by 44.7%, now holding 3,437 shares valued at $1.07 million as of the most recent SEC filing.
  • Analysts have mixed views on UnitedHealth Group, with target prices ranging from $290.00 to $440.00, resulting in a consensus rating of "Moderate Buy".
  • UnitedHealth Group announced a quarterly dividend of $2.21 per share, translating to an annualized payout of $8.84 and a yield of 2.6%.
  • Five stocks to consider instead of UnitedHealth Group.

Grove Bank & Trust lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 44.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,437 shares of the healthcare conglomerate's stock after selling 2,775 shares during the period. Grove Bank & Trust's holdings in UnitedHealth Group were worth $1,072,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Citizens National Bank Trust Department boosted its stake in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after buying an additional 1,465 shares during the last quarter. Caitlin John LLC raised its holdings in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after buying an additional 111 shares during the last quarter. Triumph Capital Management bought a new stake in UnitedHealth Group during the 2nd quarter valued at $1,324,000. Finally, Focus Partners Wealth raised its holdings in UnitedHealth Group by 5.3% during the 1st quarter. Focus Partners Wealth now owns 277,916 shares of the healthcare conglomerate's stock valued at $145,559,000 after buying an additional 14,112 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a report on Monday, August 4th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Sanford C. Bernstein upped their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, Bank of America upped their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

Read Our Latest Stock Report on UNH

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $1.90 during trading on Friday, reaching $336.72. 13,528,738 shares of the company traded hands, compared to its average volume of 13,748,202. The firm has a 50 day simple moving average of $295.67 and a 200-day simple moving average of $365.19. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $304.96 billion, a PE ratio of 14.59, a P/E/G ratio of 2.19 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines